(Q35553659)

8 August 2017

1 reference

title

Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment (English)

1 reference

vulva squamous cell carcinoma

8 August 2017

main subject

1 reference

Stephen K. Tyring

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14532899

19 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0002937803007920?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

https://api.elsevier.com/content/article/PII:S0002937803007920?httpAccept=text/plain

19 March 2024

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

American Journal of Obstetrics and Gynecology

19 March 2024

published in

1 reference

8 August 2017

volume

189

1 reference

8 August 2017

issue

3 Suppl

1 reference

8 August 2017

page(s)

S17-23

1 reference

8 August 2017

cites work

Cancer statistics, 2002

1

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia

19 March 2024

2

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

In situ and invasive vulvar cancer incidence trends (1973 to 1987)

19 March 2024

3

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia

19 March 2024

4

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Human papillomavirus-specific serologic response in vulvar neoplasia

19 March 2024

5

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Vulvar cancer: the Cinderella of gynaecological oncology

19 March 2024

6

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies

19 March 2024

7

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Vulvar intraepithelial neoplasia: historical aspects and current status

19 March 2024

8

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Heterogeneous etiology of squamous carcinoma of the vulva

19 March 2024

9

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women

19 March 2024

10

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women

19 March 2024

11

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Characteristics of patients with vulvar cancer: an analysis of 94 patients

19 March 2024

12

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Epidemiology and etiology of squamous cell carcinoma of the vulva

19 March 2024

13

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

An update on vulvar cancer

19 March 2024

14

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Optimum screening interventions for gynecologic malignancies

19 March 2024

15

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study)

19 March 2024

16

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Vulvodynia: an indicator or even an early symptom of vulvar cancer

19 March 2024

17

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Benign vulvar disorders. Identifying features, practical management of nonneoplastic conditions and tumors

19 March 2024

20

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

19 March 2024

Lichen sclerosus

22

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia.

19 March 2024

23

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Clinico-pathological profile of carcinoma of the vulva

19 March 2024

28

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression

19 March 2024

29

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases

19 March 2024

30

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

The contribution of MIB 1 in the accurate grading of vulvar intraepithelial neoplasia

19 March 2024

31

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Tumor proliferation in squamous cell carcinoma of the vulva

19 March 2024

32

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Diagnosis and management of vulvar carcinoma

19 March 2024

35

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva

19 March 2024

36

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Prognostic factors for survival in invasive squamous cell vulvar carcinoma: a univariate analysis

19 March 2024

37

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas

19 March 2024

38

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

19 March 2024

39

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid

19 March 2024

41

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group

19 March 2024

42

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Gynecologic Oncology Group randomized trials of combined technique therapy for vulvar cancer.

19 March 2024

43

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy

19 March 2024

44

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Comparison of CO2 laser surgery and loop electrosurgical excision/fulguration procedure (LEEP) for the treatment of vulvar intraepithelial neoplasia (VIN).

19 March 2024

45

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

19 March 2024

Carcinoma of the vulva

47

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Surgical management of vulvar cancer

19 March 2024

48

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva

19 March 2024

50

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Radical vulvectomy. The decision for the incision

19 March 2024

51

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy

19 March 2024

52

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

V--Y flap for perineal reconstruction following modified approach to vulvectomy in vulvar cancer

19 March 2024

53

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Skin bridge recurrences in vulvar cancer: frequency and management

19 March 2024

55

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Conservative management of early vulvar cancer

19 March 2024

56

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease

19 March 2024

57

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study.

19 March 2024

58

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Frequency of invasive cancer in surgically excised vulvar lesions with intraepithelial neoplasia (VIN 3)

19 March 2024

60

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999.

19 March 2024

61

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence

19 March 2024

62

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva

19 March 2024

63

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid

19 March 2024

64

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial

19 March 2024

65

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%

19 March 2024

66

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

19 March 2024

69

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

19 March 2024

70

1 reference

https://api.crossref.org/works/10.1067/S0002-9378(03)00792-0

19 March 2024

Identifiers

1 reference

8 August 2017

1 reference